Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review

G Di Sario, V Rossella, ES Famulari, A Maurizio… - Frontiers in …, 2023 - frontiersin.org
In the last years, liquid biopsy gained increasing clinical relevance for detecting and
monitoring several cancer types, being minimally invasive, highly informative and replicable …

Unlocking the potential of circulating miRNAs in the breast cancer neoadjuvant setting: a systematic review and meta-analysis

P Tiberio, M Gaudio, S Belloni, S Pindilli, C Benvenuti… - Cancers, 2023 - mdpi.com
Simple Summary In recent decades, neoadjuvant chemotherapy has proven to be a viable
therapeutic option, particularly in cases of high-risk early or locally advanced breast cancer …

Reusability report: Evaluating reproducibility and reusability of a fine-tuned model to predict drug response in cancer patient samples

E So, F Yu, B Wang, B Haibe-Kains - Nature Machine Intelligence, 2023 - nature.com
Abstract Machine learning and artificial intelligence methods are increasingly being used in
personalized medicine, including precision oncology. Ma et al.(Nature Cancer 2021) have …

Exploring the potential role of circulating microRNAs as biomarkers for predicting clinical response to neoadjuvant therapy in breast cancer

LM Ruiz-Manriquez, C Villarreal-Garza… - International Journal of …, 2023 - mdpi.com
Breast cancer (BC) is a leading cause of cancer-related deaths among women worldwide.
Neoadjuvant therapy (NAT) is increasingly being used to reduce tumor burden prior to …

Baseline expression of exosomal miR-92a-3p and miR-221-3p could predict the response to first-line chemotherapy and survival in metastatic colorectal cancer

A Gherman, L Balacescu, C Popa, C Cainap… - International Journal of …, 2023 - mdpi.com
The status of predictive biomarkers in metastatic colorectal cancer is currently
underdeveloped. Our study aimed to investigate the predictive value of six circulating …

Potential role of circulating miRNAs for breast cancer management in the neoadjuvant setting: A road to pave

C Benvenuti, P Tiberio, M Gaudio, F Jacobs… - Cancers, 2023 - mdpi.com
Simple Summary In breast cancer management, neoadjuvant chemotherapy is well
established as therapeutic choice for selected high-risk early or locally advanced breast …

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood …

P Decruyenaere, E Giuili, K Verniers, J Anckaert… - Frontiers in …, 2023 - frontiersin.org
Introduction Diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell
lymphoma (PMBCL) are aggressive histological subtypes of non-Hodgkin's lymphoma …

[HTML][HTML] The emerging role of extracellular vesicles and particles in prostate cancer diagnosis, and risk stratification

Q Wang, B Pang, J Bucci, J Jiang, Y Li - Biochimica et Biophysica Acta …, 2024 - Elsevier
Current approaches for prostate cancer (PCa) diagnosis and risk stratification require
greater accuracy. Extracellular vesicles and particles (EVPs) containing diverse cargos from …

[HTML][HTML] Characterizing the Cell-Free Transcriptome in a Humanized Diffuse Large B-Cell Lymphoma Patient-Derived Tumor Xenograft Model for RNA-Based Liquid …

P Decruyenaere, W Daneels, A Morlion… - International Journal of …, 2024 - mdpi.com
The potential of RNA-based liquid biopsy is increasingly being recognized in diffuse large B-
cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma. This study …

Rank-based sequential feature selection for high-dimensional accelerated failure time models with main and interaction effects

K Yu, S Luo - Computational Statistics & Data Analysis, 2024 - Elsevier
High-dimensional accelerated failure time (AFT) models are commonly used regression
models in survival analysis. Feature selection problem in high-dimensional AFT models is …